Skip to content
DataLookout
Menu

NCT05876923

The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 14 versions: 13 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 5 words Show 7 more changesShow less
    • Enrollment closed, study ongoing
    • Primary completion date changed from estimate of Mar 13, 2028 to Sep 18, 2025
    • Study completion pushed from Apr 2028 to Sep 18, 2029
    • Enrollment target: estimated 70 to confirmed 65
    • Secondary endpoints expanded, about 36 words
    • Study description revised
    • Site details revised at 2 of 2 sites
  2. Minor Study title shortened, about 3 wordsv12
  3. Minor Site contacts updated at 2 of 2 sitesv11
  4. Notable Start date: Mar 13, 2023 to Jun 12, 2023
    • Interventions: Best Practice (Other), Biospecimen Collection (Procedure), Cardiopulmonary Exercise Testing (Other), Dual X-ray Absorptiometry (Procedure)… to Best Practice (Other), Biospecimen Collection (Procedure), Cardiopulmonary Exercise Testing (Other), Dual X-ray Absorptiometry (Procedure)…
    • Study description expanded, about 21 words
    v10
  5. Notable Enrollment target: 132 to 70
    • Site contacts updated at 2 of 2 sites
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. Minor Site contacts updated at 1 of 2 sitesv8
  2. Notable Eligibility criteria expanded, about 18 wordsv7
  3. Minor Study title expanded, about 3 wordsv6
  4. Notable Eligibility criteria expanded, about 71 wordsv5 Show 4 more changesShow less
    • Enrollment target: 100 to 132
    • Interventions: Biospecimen Collection (Procedure), Cardiopulmonary Exercise Testing (Other), Dual X-ray Absorptiometry (Procedure), Electronic Health… to Best Practice (Other), Biospecimen Collection (Procedure), Cardiopulmonary Exercise Testing (Other), Dual X-ray Absorptiometry (Procedure)…
    • Study description expanded, about 269 words
    • Study arms: 2 to 5
  5. Notable Trial status: Suspended to Recruiting
    • Site details revised at 2 of 2 sites
    v4
  6. Study Status, Referencesv3
  7. Stopped Trial status: Recruiting to Suspended Sponsor's reason: Number of patients interested in participating has exceeded the number of patients we have funding for.
    • Site details revised at 2 of 2 sites
    v2
  1. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Assess circulating immune cell abundance and function pre-intervention
Timeframe: Baseline
Assess circulating immune cell mobilization and function post-intervention
Timeframe: 12 weeks (at end of 12-week intervention)

Secondary (5)

Assess circulating immune cell mobilization and function in follow-up
Fatigue - SCFS (indolent NHL only)
Fatigue - FACIT-F (indolent NHL only)
Quality of Life - EORTC-QLQ-C30 (indolent NHL only)
Physical Activity - GPAQ (indolent NHL only)

Arms and interventions

Aim 1 (vitals, spirometry, CPET, blood samples, DEXA)Experimental

Participants undergo measurement of height/weight and vital signs (blood pressure, temperature, heart and breathing rate), complete lung function testing (spirometry), undergo an exercise test (CPET), and undergo collection of blood samples on study. Participants may also undergo DEXA scan on study.

Aim 2 (aerobic based training program, Aim 1 activities)Experimental

CLL patients complete aerobic based training program on study. Patients then complete all Aim 1 activities again after completion of aerobic based training program.

Aims 3-4 arm I (indolent NHL usual care)Active comparator

Indolent NHL patients undergo measurement of height/weight and vital signs (blood pressure, temperature, heart and breathing rate), complete lung function testing (spirometry), undergo an exercise test (CPET), and undergo collection of blood samples on study. Participants may also undergo DEXA scan on study. Patients undergo muscular strength and functional endurance measurements of hand grip strength, upper body power via weighted chest pass, and leg strength with the timed chair stand test and 6MWT. Patients receive usual care on study.

Aims 3-4 arm II (indolent NHL aerobic based training program)Active comparator

Indolent NHL patients undergo measurement of height/weight and vital signs (blood pressure, temperature, heart and breathing rate), complete lung function testing (spirometry), undergo an exercise test (CPET), and undergo collection of blood samples on study. Participants may also undergo DEXA scan on study. Patients undergo muscular strength and functional endurance measurements of hand grip strength, upper body power via weighted chest pass, and leg strength with the timed chair stand test and 6MWT. Patients complete aerobic based training program on study. Patients then complete all baseline activities again after completion of aerobic based training program.

Aim 5 (repeat baseline activities)Experimental

All patients from Aims 3-4 will be invited to repeat Aims 3-4 baseline activities.

Procedures: Biospecimen Collection, Dual X-ray Absorptiometry, Physical Examination, Spirometry

Other: Cardiopulmonary Exercise Testing, Electronic Health Record Review, Exercise Intervention, Questionnaire Administration, Physical Performance Testing, Best Practice

Sites

2 sites in 1 country